Board of Directors

  • Leadership User
    Mr David Williams

    B.Ec (Hons), M.Ec, FAICD

    Non-executive Chairman

    Mr Williams was appointed as a Non- executive Director on 28 February 2014 and Chairman on 13 March 2014. Mr Williams is an experienced Director and investment banker with a proven track record in business development and strategy, as well as in mergers and acquisitions and capital raising. He possesses 35 years’ experience working with and advising ASX-listed companies in the food, medical device and pharmaceutical sectors. Mr Williams is currently Chairman of ASX-listed Medical Developments International Ltd (ASX: MVP), Chairman of RMA Global Limited and is Managing Director of corporate advisory firm Kidder Williams Ltd. Mr Williams resigned as Non-executive Director of IDT (ASX: IDT) on 19 May 2015.

  • Mr Swami Raote

    B. Pharmacy, MBA

    Chief Executive Officer

    Mr Raote was appointed Chief Executive Officer of PolyNovo Limited on 29 July 2022. Mr Raote held the position of Worldwide President, Vision Care from 2017 to 2021, a division of Johnson & Johnson the world’s largest medical, pharmaceutical and consumer healthcare company where Mr Raote had a 30-year career. Prior to the Vision Care role, from 2014 to 2016 Mr Raote served a dual role as the Area Vice President, Medical Devices for North Asia and Vice President for Ethicon, Asia Pacific. From 2009 to 2014 Mr Raote served in a variety of roles across India for Johnson & Johnson including Managing Director for Janssen India and Area Managing Director ASEAN and India. Mr Raote was also President Director in Indonesia from 2004 to 2008. Mr Raote’s early career included leadership roles across Johnson & Johnson Asia Pacific in sales, marketing, supply chain, finance, and IT. Mr Raote is currently a Non-executive Director of EOS Vision in China and holds a number of advisory roles to private and government institutions.

  • Leadership User
    Mr Leon Hoare

    GradDipBus, AssocDipAppSc(Ortho), GAICD

    Non-executive Director

    Mr Hoare was appointed a Director of PolyNovo on 27 January 2016. Mr Hoare is also Managing Director of Lohmann & Rauscher (Australia and New Zealand), a privately owned, multinational medical device company. Previously Mr Hoare was Managing Director of Smith & Nephew (Australia/NZ) until the end of 2015, one of Smith & Nephew’s largest global subsidiaries outside the US. He served as President of Smith & Nephew’s Asia-Pacific Advanced Wound Management (AWM) business for five years and was a member of the Global Executive Management for the AWM Division. In his 24 years with Smith & Nephew, he also held roles in marketing, divisional and general management. Mr Hoare’s career also includes a senior role at Bristol-Myers Squibb in surgical products, and Vice Chair of Australia’s peak medical device body, Medical Technology Association of Australia. Mr Hoare is currently a Non-Executive Director of Medical Developments International Ltd (ASX: MVP).

  • Leadership User
    Mr Bruce Rathie

    B.Comm, LLB, MBA, FAIM, FAICD, FGIA

    Non-executive Director

    Mr Rathie is an experienced Company Director with a finance and legal background. He practised as a partner in a large legal firm and acted as Senior Corporate Counsel to Bell Resources Limited in its early years. He then studied for his MBA in Geneva and embarked on his 15 year investment banking career. When Head of the Industrial Franchise Group at Salomon Smith Barney he led Salomon’s roles in the Federal Government’s privatisation of Qantas, Commonwealth Bank (CBA3) and Telstra (T1). He now has over 19 years’ experience as a full time professional Non-executive Director. He is currently Chairman of Capricorn Mutual Limited and a Non-executive Director of Capricorn Society Limited, Australian Meat Processors Limited and Netlinkz Limited. In the medical device space, he is Chairman of about to be ASX listed 4DMedical Limited and was previously Chairman of ASX listed Anteo Diagnostics Limited and a Director of Compumedics Limited and USCOM Limited. He has been a Non-executive Director of PolyNovo since February 2010.

  • Dr Robyn Elliott

    BSc (Hons) Chemistry, PhD Inorganic Chemistry

    Non-executive Director

    Dr Elliott is currently Senior Director for Strategic Expansion Projects at CSL Behring, previously she was the Managing Director at IDT Australia and commenced her career at DBL Faulding. Dr Elliott has a proven track record in product development, clinical trials, regulatory affairs, audits, quality management and operational strategy. At CSL, her worldwide experience in new plant development and strategy, regulatory affairs and audit will be invaluable to PolyNovo as the company scales its operations globally.

  • Ms Christine Emmanuel

    BSc (Hons) Chemistry, MSc Enterprise

    Non-executive Director

    Ms Emmanuel is an accomplished patent and trademark attorney, and a business development professional with more than 30 years’ local and international experience. Ms Emmanuel has a Bachelor of Science with a major in Economics (Hons: Chem) from Monash University, Certificate in Intellectual Property Law from Queen Mary College, University of London, Masters of Enterprise from Melbourne University. She is a member of the Chartered Institute of Patent Attorneys UK and has been on the Board of the Institute of Patent and Trade Mark Attorneys of Australia since 2010. Ms Emmanuel is currently Executive Manager of Business Development and Commercial at the CSIRO, having founded and led the management of CSIRO’s IP portfolio for over 10 years and managed the growth of the CSIRO equity portfolio for the last 5 years. Previously she was in-house IP Counsel for Unilever in the UK and practised as a patent and trademark attorney for Wilson Gunn (UK) and Davies Collison Cave and Griffith Hack in Melbourne.

  • Mr Andrew Lumsden

    MA (Hons) in Accountancy & Finance, CA, AGIA ACG, MAICD

    Non-executive Director

    Mr Lumsden was appointed a Director of PolyNovo on 4 June 2021. He is an accomplished Chartered Accountant and finance executive with more than 20 years’ experience locally and internationally. He holds a Master of Arts in Accountancy and Finance (First Class Hons), is an Associate of The Chartered Governance Institute and a member of the Australian Institute of Company Directors. Mr Lumsden is currently Global Chief Operating Officer of Wellcom Group Pty Ltd (formerly Wellcom Group Limited) having previously held the roles of Chief Financial Officer and Company Secretary. Prior to joining Wellcom, Mr Lumsden was a Senior Manager within the Audit and Assurance practice of PricewaterhouseCoopers.